Sunmax Biotechnology Co

Sunmax Biotechnology Co Inventory

The Inventory of Sunmax Biotechnology Co (4728.TWO) as of Nov 10, 2026 is 152.66 M TWD. In the previous year, Inventory was 157.36 M TWD — a change of -2.99% (lower).

Inventory

152.66 MTWD

YoY

-2.99%

Last updated:

Inventory of Sunmax Biotechnology Co is 2025 152.66 M TWD. Inventory of Sunmax Biotechnology Co was 2024 157.36 M TWD. It decreases by -2.99% lower compared to the previous year.

The Sunmax Biotechnology Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
26.42 M TWD
Jan 1, 2019
41.20 M TWD
Jan 1, 2020
25.33 M TWD
Jan 1, 2021
54.74 M TWD
Jan 1, 2022
73.79 M TWD
Jan 1, 2023
93.67 M TWD
Jan 1, 2024
157.36 M TWD
Jan 1, 2025
152.66 M TWD
The Sunmax Biotechnology Co Inventory history
YEARInventoryYoY
152.66 MTWD-2.99%
157.36 MTWD+67.99%
93.67 MTWD+26.94%
73.79 MTWD+34.81%
54.74 MTWD+116.09%
25.33 MTWD-38.51%
41.20 MTWD+55.92%
26.42 MTWD+1.01%
26.16 MTWD+9.12%
23.97 MTWD-15.16%
28.25 MTWD-10.13%
31.44 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sunmax Biotechnology Co Stock analysis

What does Sunmax Biotechnology Co do? SunMax Biotechnology Co., Ltd. generates revenue through the development, manufacturing, and commercialization of medical devices, biomedical materials, and bio surgical products. Its major products include collagen, collagen implants, microfiber collagen hemostat, collagen absorbable hemostat pads, healthcare products, and medical collagen application equipment. These products are sold to customers in the medical and beauty care industries across Taiwan, Mainland China, and other regions. The company's distribution focuses on these key markets, leveraging its product portfolio for healthcare and aesthetic applications. The firm's product line targets both medical and beauty care sectors, with collagen-based solutions serving as core offerings. Medical collagen application equipment supports clinical procedures, while collagen implants and hemostat products address surgical and wound care needs. The company's presence in Taiwan, Mainland China, and other regions enables it to serve diverse healthcare markets with standardized product offerings. SunMax Biotechnology's revenue streams are derived from the sale of collagen-based medical devices and equipment, with a focus on applications in surgery, wound care, and aesthetic treatments. By distributing its products through established channels in Taiwan, Mainland China, and other regions, the company capitalizes on demand for biocompatible materials in healthcare and beauty care industries. Sunmax Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunmax Biotechnology Co stock

Inventory of Sunmax Biotechnology Co is 152.66 M TWD in 2025.

Inventory of Sunmax Biotechnology Co changed from 157.36 M TWD to 152.66 M TWD, representing a -2.99% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Sunmax Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Sunmax Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sunmax Biotechnology Co

All Key Metrics — Sunmax Biotechnology Co